HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by King, A. P.J. Articles by Carter-Su, C. Search for Related Content PubMed PubMed Citation Articles by King, A. P.J. Articles by Carter-Su, C. Social Bookmarking                      What's this?

Volume 271, Number 30, Issue of July 26, 1996 pp. 18088-18094
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Distinct Cytoplasmic Domains of the Growth Hormone Receptor Are Required for Glucocorticoid- and Phorbol Ester-induced Decreases in Growth Hormone (GH) Binding
THESE DOMAINS ARE DIFFERENT FROM THAT REPORTED FOR GH-INDUCED RECEPTOR INTERNALIZATION

(Received for publication, December 29, 1995, and in revised form, April 16, 1996)

Anthony P. J. King , Min-Jen Tseng , Craig D. Logsdon , Nils Billestrup ^¶ and Christin Carter-Su

From the  Department of Physiology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0622 and the ^¶ Hagedorn Research Laboratory, DK-2820 Gentofte, Denmark

Glucocorticoids inhibit growth in children and antagonize the growth-promoting action of GH in peripheral tissues. Recently, they have been shown to decrease GH binding. In this study we examine the molecular mechanisms by which the glucocorticoid dexamethasone (DEX) and the phorbol ester phorbol myristate acetate (PMA) decrease cellular GH binding. In 3T3-F442A fibroblasts, DEX and PMA decrease the number of GH receptors (GHRs) capable of binding GH by 50% (t1/2 = 6 h) and 70% (t1/2 = 15 min), respectively. Neither appear to decrease the total number of cellular GHR. Rather, they appear to redistribute GHRs away from the plasma membrane or inactivate GHRs on the membrane such that they cannot bind GH. DEX and PMA also decrease GH-induced tyrosyl phosphorylation of GHR and JAK2 with a magnitude and time course correlating with that of inhibition of GH binding. DEX- and PMA-induced reductions of GH binding are also observed in a Chinese hamster ovary (CHO) cell line stably transfected with a rat liver GHR cDNA, further arguing that DEX and PMA act post-translationally on GHR. Using mutant GHRs stably expressed in CHO cells, amino acids 455-506 and tyrosines 333 and/or 338 of GHR were shown to be required for maximal DEX-induced inhibition of GH binding. DEX decreased GH binding to a GHR mutant F346A, which is reported to be deficient in ligand-induced internalization, suggesting that DEX decreases GH binding by a mechanism distinct from that of ligand-induced GHR internalization. PMA reduced GH binding to CHO cells expressing all GHR mutants tested. However, deletion of the C-terminal 132 amino acids decreased this effect, suggesting that at least one component of PMA action on GHR requires amino acids 507-638. These data suggest that distinct pathways mediate the effects of GH, DEX, and PMA on GHR number in the plasma membrane.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. M. Very and M. A. Sheridan Somatostatin regulates hepatic growth hormone sensitivity by internalizing growth hormone receptors and by decreasing transcription of growth hormone receptor mRNAs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1956 - R1962. [Abstract] [Full Text] [PDF]

				P. Kotokorpi, C. Gardmo, C. S. Nystrom, and A. Mode Activation of the Glucocorticoid Receptor or Liver X Receptors Interferes with Growth Hormone-Induced akr1b7 Gene Expression in Rat Hepatocytes Endocrinology, December 1, 2004; 145(12): 5704 - 5713. [Abstract] [Full Text] [PDF]

				R. Ishida-Takahashi, S. Uotani, T. Abe, M. Degawa-Yamauchi, T. Fukushima, N. Fujita, H. Sakamaki, H. Yamasaki, Y. Yamaguchi, and K. Eguchi Rapid Inhibition of Leptin Signaling by Glucocorticoids in Vitro and in Vivo J. Biol. Chem., May 7, 2004; 279(19): 19658 - 19664. [Abstract] [Full Text] [PDF]

				V. Beauloye, B. Willems, V. de Coninck, S. J. Frank, M. Edery, and J.-P. Thissen Impairment of Liver GH Receptor Signaling by Fasting Endocrinology, March 1, 2002; 143(3): 792 - 800. [Abstract] [Full Text] [PDF]

				R. Guan, Y. Zhang, J. Jiang, C. A. Baumann, R. A. Black, G. Baumann, and S. J. Frank Phorbol Ester- and Growth Factor-Induced Growth Hormone (GH) Receptor Proteolysis and GH-Binding Protein Shedding: Relationship to GH Receptor Down-Regulation Endocrinology, March 1, 2001; 142(3): 1137 - 1147. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. Jiang, R. A. Black, G. Baumann, and S. J. Frank Tumor Necrosis Factor-{{alpha}} Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation Endocrinology, December 1, 2000; 141(12): 4342 - 4348. [Abstract] [Full Text] [PDF]

				P. L. Bergad, S. J. Schwarzenberg, J. T. Humbert, M. Morrison, S. Amarasinghe, H. C. Towle, and S. A. Berry Inhibition of growth hormone action in models of inflammation Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1906 - C1917. [Abstract] [Full Text] [PDF]

				P. L. Bergad, H. C. Towle, and S. A. Berry Yin-yang 1 and Glucocorticoid Receptor Participate in the Stat5-mediated Growth Hormone Response of the Serine Protease Inhibitor 2.1 Gene J. Biol. Chem., March 10, 2000; 275(11): 8114 - 8120. [Abstract] [Full Text] [PDF]

				L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892. [Abstract] [Full Text] [PDF]

				C. A. Gebert, S.-H. Park, and D. J. Waxman Termination of Growth Hormone Pulse-Induced STAT5b Signaling Mol. Endocrinol., January 1, 1999; 13(1): 38 - 56. [Abstract] [Full Text]

				E. Canalis Editorial: Inhibitory Actions of Glucocorticoids on Skeletal Growth. Is Local Insulin-Like Growth Factor I to Blame? Endocrinology, July 1, 1998; 139(7): 3041 - 3042. [Full Text] [PDF]

				J. Alele, J. Jiang, J. F. Goldsmith, X. Yang, H. G. Maheshwari, R. A. Black, G. Baumann, and S. J. Frank Blockade of Growth Hormone Receptor Shedding by a Metalloprotease Inhibitor Endocrinology, April 1, 1998; 139(4): 1927 - 1935. [Abstract] [Full Text] [PDF]

				J. F. Goldsmith, S. J. Lee, J. Jiang, and S. J. Frank Growth hormone induces detergent insolubility of GH receptors in IM-9 cells Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E932 - E941. [Abstract] [Full Text] [PDF]